PAPER Bruno V, Battaglia G, Copani A, D'Onofrio M, Di Iorio P, De Blasi A, Melchiorri D, Flor PJ, Nicoletti F

Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.

J Cereb Blood Flow Metab. 2001 Sep;21(9):1013-33. PubMed.

PAPER Moawad MA

Possible relationship between statin use and decreased incidence of dementia: are we ready for a new indication for these drugs?

Arch Intern Med. 2001 Aug 13-27;161(15):1909-10. PubMed.

PAPER Riddell DR, Christie G, Hussain I, Dingwall C

Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts.

Curr Biol. 2001 Aug 21;11(16):1288-93. PubMed.

PAPER Isles A

A new function for Alzheimer's protein.

Trends Genet. 2001 Sep;17(9):495. PubMed.

PAPER Wiltfang J, Esselmann H, Cupers P, Neumann M, Kretzschmar H, Beyermann M, Schleuder D, Jahn H, Rüther E, Kornhuber J, Annaert W, De Strooper B, Saftig P

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.

J Biol Chem. 2001 Nov 16;276(46):42645-57. PubMed.

PAPER de Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, Rusinek H, Tsui W, Kandil E, Scherer AJ, Roche A, Imossi A, Thorn E, Bobinski M, Caraos C, Lesbre P, Schlyer D, Poirier J, Reisberg B, Fowler J

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).

Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10966-71. Epub 2001 Aug 28 PubMed.

PAPER Lipton AM, Cullum CM, Satumtira S, Sontag E, Hynan LS, White CL, Bigio EH

Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias.

Arch Neurol. 2001 Aug;58(8):1233-9. PubMed.

PAPER Mungas D, Reed BR, Ellis WG, Jagust WJ

The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease.

Arch Neurol. 2001 Aug;58(8):1243-7. PubMed.

PAPER Kril JJ, Halliday GM

Alzheimer's disease: its diagnosis and pathogenesis.

Int Rev Neurobiol. 2001;48:167-217. PubMed.

PAPER Kéri S, Kálmán J, Kelemen O, Benedek G, Janka Z

Are Alzheimer's disease patients able to learn visual prototypes?

Neuropsychologia. 2001;39(11):1218-23. PubMed.

PAPER Grimes CA, Jope RS

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

Prog Neurobiol. 2001 Nov;65(4):391-426. PubMed.

PAPER Chandra RK

Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects.

Nutrition. 2001 Sep;17(9):709-12. PubMed. RETRACTED

PAPER McGrath LT, McGleenon BM, Brennan S, McColl D, McILroy S, Passmore AP

Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde.

QJM. 2001 Sep;94(9):485-90. PubMed.

PAPER Haass C, Steiner H

Protofibrils, the unifying toxic molecule of neurodegenerative disorders?

Nat Neurosci. 2001 Sep;4(9):859-60. PubMed.

PAPER Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Näslund J, Lannfelt L

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

Nat Neurosci. 2001 Sep;4(9):887-93. PubMed.